Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118


Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa.

Lee JY, Chung ES, Na IY, Kim H, Shin D, Ko KS.

J Antimicrob Chemother. 2014 Nov;69(11):2966-71. doi: 10.1093/jac/dku238. Epub 2014 Jul 2.


Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.

Lee JY, Ko KS.

Diagn Microbiol Infect Dis. 2014 Mar;78(3):271-6. doi: 10.1016/j.diagmicrobio.2013.11.027. Epub 2013 Dec 7.


Colistin resistance in Pseudomonas aeruginosa that is not linked to arnB.

Chung ES, Lee JY, Rhee JY, Ko KS.

J Med Microbiol. 2017 Jun;66(6):833-841. doi: 10.1099/jmm.0.000456.


Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.

Fernández L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock RE.

Antimicrob Agents Chemother. 2010 Aug;54(8):3372-82. doi: 10.1128/AAC.00242-10. Epub 2010 Jun 14.


Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.

Ly NS, Yang J, Bulitta JB, Tsuji BT.

Antimicrob Agents Chemother. 2012 Jun;56(6):3453-6. doi: 10.1128/AAC.06380-11. Epub 2012 Apr 2.


The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ.

Chambers JR, Sauer K.

J Bacteriol. 2013 Oct;195(20):4678-88. doi: 10.1128/JB.00834-13. Epub 2013 Aug 9.


PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.

Miller AK, Brannon MK, Stevens L, Johansen HK, Selgrade SE, Miller SI, Høiby N, Moskowitz SM.

Antimicrob Agents Chemother. 2011 Dec;55(12):5761-9. doi: 10.1128/AAC.05391-11. Epub 2011 Oct 3.


Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa.

McPhee JB, Bains M, Winsor G, Lewenza S, Kwasnicka A, Brazas MD, Brinkman FS, Hancock RE.

J Bacteriol. 2006 Jun;188(11):3995-4006.


Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii.

Park YK, Choi JY, Shin D, Ko KS.

Int J Antimicrob Agents. 2011 Jun;37(6):525-30. doi: 10.1016/j.ijantimicag.2011.02.008. Epub 2011 Apr 14.


Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.

Gutu AD, Sgambati N, Strasbourger P, Brannon MK, Jacobs MA, Haugen E, Kaul RK, Johansen HK, Høiby N, Moskowitz SM.

Antimicrob Agents Chemother. 2013 May;57(5):2204-15. doi: 10.1128/AAC.02353-12. Epub 2013 Mar 4.


Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance.

Lee JY, Na IY, Park YK, Ko KS.

J Antimicrob Chemother. 2014 May;69(5):1248-56. doi: 10.1093/jac/dkt531. Epub 2014 Jan 27.


A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.

Muller C, Plésiat P, Jeannot K.

Antimicrob Agents Chemother. 2011 Mar;55(3):1211-21. doi: 10.1128/AAC.01252-10. Epub 2010 Dec 13.


Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system.

Jayol A, Nordmann P, Brink A, Poirel L.

Antimicrob Agents Chemother. 2015 May;59(5):2780-4. doi: 10.1128/AAC.05055-14. Epub 2015 Mar 2.


Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.

Lee JY, Choi MJ, Choi HJ, Ko KS.

Antimicrob Agents Chemother. 2015 Oct 12;60(1):609-12. doi: 10.1128/AAC.01574-15.


Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

Schurek KN, Sampaio JL, Kiffer CR, Sinto S, Mendes CM, Hancock RE.

Antimicrob Agents Chemother. 2009 Oct;53(10):4345-51. doi: 10.1128/AAC.01267-08. Epub 2009 Jul 27.


PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.

Moskowitz SM, Brannon MK, Dasgupta N, Pier M, Sgambati N, Miller AK, Selgrade SE, Miller SI, Denton M, Conway SP, Johansen HK, Høiby N.

Antimicrob Agents Chemother. 2012 Feb;56(2):1019-30. doi: 10.1128/AAC.05829-11. Epub 2011 Nov 21.


Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides.

Macfarlane EL, Kwasnicka A, Hancock RE.

Microbiology. 2000 Oct;146 ( Pt 10):2543-54.


Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N.

Antimicrob Agents Chemother. 2011 Jul;55(7):3370-9. doi: 10.1128/AAC.00079-11. Epub 2011 May 16.

Supplemental Content

Support Center